Epidemiology Controls Using Healthy Participants
The goal of this research study is to identify biologic and lifestyle factors that may increase a person's risk of developing certain types of cancer.
- Enroll healthy participants who can serve as controls for approved IRB case-control protocols ID00-098 and ID03-0250.
- Obtain detailed risk factor and food frequency questionnaires.
- Collect and store blood samples on all participants.
|Study Design:||Observational Model: Case Control
Time Perspective: Prospective
|Official Title:||Epidemiology Controls Using Healthy Participants|
- To identify biologic and lifestyle factors that may increase a person's risk of developing certain types of cancer. [ Time Frame: 6 Years ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples Without DNA
2 ½ tablespoons of blood drawn.
|Study Start Date:||June 2004|
|Estimated Primary Completion Date:||December 2015 (Final data collection date for primary outcome measure)|
Person with no history of cancer.
50 Minute Interview
Other Name: Survey
For this study, you will be asked to complete a personal interview. During the interview, you will be asked questions about your demographics (age, sex, etc.), certain environmental exposures, your medical history, family history, your diet, and your smoking and alcohol use histories. It should take around 50 minutes to complete the interview.
You will also have around 2 ½ tablespoons of blood drawn for special tests. These tests will look for any biologic factors associated with certain cancers. The interview and blood draw will be scheduled at the time and place of your convenience. You will not be informed of the results of any of the testing done with your samples.
There is a possibility that you might be contacted in the future about if researchers need clarification on any of information already collected. You are free to refuse any further participation if you wish.
This is an investigational study. Up to 1,500 participants will take part in this study.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00476632
|United States, Texas|
|University of Texas MD Anderson Cancer Center|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Sara Strom, PHD||M.D. Anderson Cancer Center|